If you are wondering whether Insulet at around $304 a share is still a smart long term buy or if the easy money has already been made, you are not alone. Let's break down what the current price really ...

Pease announced, "For the fourth quarter, we expect total Omnipod revenue growth of 27% to 30% and total company growth of 25% to 28%." She guided for fourth quarter U.S. Omnipod growth of 24% to 27% ...

Medical devices are not particularly known for bold branding. Omnipod, an insulin pump owned by Insulet, aims to change that with its own custom color created with Pantone. Last week, the 25-year-old ...

Insulet is bringing a splash of color to the diabetes technology market. Working with Pantone, the insulin pump company has created the “bright and joyful tropical orange yellow” color Omnipod Mango.

ACTON, Mass. - Insulet Corporation (NASDAQ:PODD), a $22.7 billion medical device company with impressive 26% year-over-year revenue growth, has partnered with Pantone to create "Omnipod Mango," a new ...

In an age where colours are increasingly disappearing from commercial brands, Insulet is looking to buck the trend – creating a tropical hue via its Omnipod insulin pump portfolio. The diabetes giant ...

Insulet Corporation (NASDAQ:PODD) reported second-quarter adjusted earnings of $1.17 per share, beating the consensus of 92 cents. PODD shares are rallying today. Track live prices here. The automated ...

I MOSTLY SHARE ABOUT MY DIABETES JOURNEY, MY SUGARS HAVE BEEN PRETTY GOOD THE LAST THREE DAYS, SO WE LOVE THAT. THAT’S A TOTAL SLAY. LAUREN QUINN IS A TYPE ONE DIABETIC. OBVIOUSLY THE BEGINNING. IT ...

OKLAHOMA CITY — Medicaid recipients in Oklahoma who have diabetes may benefit from a proposed change in the way the state covers costs of automated insulin management systems. On Monday, lawmakers on ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has cleared a tubeless automated insulin ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The U.S. Food and Drug ...

(HealthDay News) — On Monday, the US Food and Drug Administration approved the Insulet Omnipod 5 insulin delivery system for patients with type 2 diabetes. It is the first such system for use by ...